Brief: Caliway Biopharmaceuticals Expects IND Approvals For Cbl-514

Caliway Biopharmaceuticals Co

23/10/2024 17:02

Oct 23 (Reuters) - Caliway Biopharmaceuticals Co Ltd
 6919.TW :
    * CALIWAY BIOPHARMACEUTICALS-EXPECTS IND APPROVALS FOR
CBL-514
FROM U.S. FDA,HEALTH CANADA BY 2025, SUBJECT RECRUITMENT
EXPECTED TO INITIATE IN H2 2025

Source text for Eikon:  ID:nPn588R4ha 
Further company coverage:  6919.TW 

 ((Reuters.Briefs@thomsonreuters.com;))